New Legislative Initiative to Address Nitazene Threat
Three Republican senators are stepping forward with a new coordinated effort to tackle nitazene, a synthetic opioid that’s starting to emerge as a potential crisis similar to fentanyl. Although it hasn’t yet entered mainstream awareness, both law enforcement and health officials are increasingly concerned about its risks.
Sens. Eric Schmidt from Missouri, Pete Ricketts from Nebraska, and Dave McCormick from Pennsylvania have introduced three key bills aimed at curbing the rise of nitazene through a combination of law enforcement strategies, technological advancements, and foreign policy adjustments. This push marks one of the most assertive Congressional actions to preempt what experts caution could be a deadly escalation in the ongoing opioid epidemic.
One of these bills, the DETECT Nitazene Act, mandates that the Department of Homeland Security collaborate with the Drug Enforcement Administration to create and implement new technology capable of detecting even trace amounts of nitazene. It also modifies the Homeland Security Act to ensure nitazene is recognized in federal efforts to combat illegal substances.
Additionally, Ricketts and McCormick have partnered with Schmidt and Sen. Ruben Gallego (D-Ariz.) to propose the Nitazene Control Act. This legislation aims to permanently categorize nitazene as a Schedule I controlled substance, aligning it with drugs like heroin and fentanyl.
Concerns About Increasing Overdose Deaths
Interestingly, nitazene was once a neglected laboratory creation, but it started popping up in toxicology and seizure reports across North America, Europe, and other regions around 2019. Unfortunately, it often contaminates counterfeit pills and powders, often without the user realizing, meaning even minuscule quantities can be lethal.
The third piece of legislation, the Nitazene Sanctions Act, aims to target the supply chain from China responsible for synthetic opioids. It seeks to broaden sanctions on individuals and entities in China who play a role in the production of nitazene, pushing the State Department and Department of Justice to establish a unified approach to halt the precursor chemicals from reaching the U.S.
“Nitazene could become the next fentanyl crisis,” Ricketts remarked, emphasizing urgency. He noted, “Thousands of people in Europe have already suffered tragic losses, and it’s only a matter of time before it reaches our shores. This legislation is critical to stop those in Communist China who facilitate this danger.”
Schmidt reaffirmed this sentiment, stating that nitazene, primarily originating from China, poses a serious threat. “The Nitazene Sanctions Act aims to combat this perilous drug with impactful sanctions,” he added.
A Wakeup Call
Mr. McCormick pointed out that the rising severity of the issue should serve as a significant alert. “Considering that nitazene is reportedly more lethal than fentanyl, which caused nearly 4,000 deaths in Pennsylvania last year, it should concern us all. We need to act before this escalates into another drug epidemic,” he stressed.
Nitazene belongs to a class of synthetic opioids termed benzimidazole opioids. Initially developed in the 1950s as an experimental analgesic, it was never approved due to its extreme potency and overdose risks. Estimates suggest it might be five to nine times more potent than fentanyl, with some versions being nearly 40 times more powerful, according to the CDC.
Although nitazene’s emergence reflects an alarming trend, the actual scale of the crisis is tricky to ascertain. Many state toxicology systems and the CDC’s overdose tracking scheme still fail to differentiate nitazene from other synthetic opioids, creating substantial gaps in available data.
Unlike traditional opiate drugs, nitazene can be produced almost anywhere since it relies on readily accessible precursor chemicals. U.S. officials have alerted that Chinese manufacturers could easily synthesize these compounds, which might lead to a dangerous influx of nitazene into American markets.
The combined efforts of the DETECT Nitazene Act, the Nitazene Regulation Act, and the Nitazene Sanctions Act underline a determined Republican initiative to confront this emerging threat comprehensively. While fentanyl continues to be a significant contributor to the overdose crisis in America, there’s a growing apprehension that nitazene may represent an even deadlier challenge. Lawmakers stress the importance of proactive measures before this situation spirals out of control.
